Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1540841
PUBLISHER: IMARC | PRODUCT CODE: 1540841
Neurodegenerative Disease Treatment Market Report by Indication, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032
PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 114.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.
Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.
The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type, route of administration and distribution channel.
Breakup by Indication:
Multiple Sclerosis
Parkinson's Disease
Alzheimer's Disease
Spinal Muscular Atrophy (SMA)
Huntington's Disease
Others
Breakup by Drug Type:
N-methyl-D-aspartate Receptor Antagonists
Selective Serotonin Reuptake Inhibitors
Dopamine Inhibitors
Others
Breakup by Route of Administration:
Oral
Injectable
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.
Key Questions Answered in This Report:
- How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global neurodegenerative disease treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A3102
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurodegenerative Disease Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Multiple Sclerosis
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Parkinson's Disease
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Alzheimer's Disease
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Spinal Muscular Atrophy (SMA)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Huntington's Disease
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 N-methyl-D-aspartate Receptor Antagonists
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Selective Serotonin Reuptake Inhibitors
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Dopamine Inhibitors
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Biogen
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Boehringer Ingelheim International GmbH
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 F. Hoffmann-La Roche AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 GlaxoSmithKline Plc
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 SWOT Analysis
- 15.3.5 Merck & Co. Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Novartis AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Pfizer Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Sanofi S.A
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Teva Pharmaceutical Industries Ltd.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 UCB S.A
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Biogen
Product Code: SR112024A3102
List of Figures
- Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2023
- Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2023
- Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2023
- Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
- Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2023
- Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Neurodegenerative Disease Treatment (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Neurodegenerative Disease Treatment (Huntington's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2023
- Figure 90: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
- Figure 91: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
- Figure 92: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2024-2032
- Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
- Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
- Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.